Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

Published:2018-11 Issue: Volume:195 Page:181-190
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Perez-Moreiras Jose V.,Gomez-Reino Juan J.,Maneiro Jose R.,Perez-Pampin Eva,Romo Lopez Angel,Rodríguez Alvarez Fernando M.,Castillo Laguarta Jesús M.,del Estad Cabello Aurora,Gessa Sorroche María,España Gregori Enrique,Sales-Sanz Marco^ORCID,Gomez-Reino Juan J.,Maneiro Jose,Tome Martinez de Rituerto Maria A.,Pampin Eva Perez,Perez-Moreiras Jose V.,Alvarez Alejandro,Lopez Angel Romo,Troyano Juan,Niño Cristina,Vico Eva,Montañez Zorrilla Maria C.,Sanz Marco Sales,Martín Ucero Ana M.,Revenga Marcelino,Gregori Enrique España,Pérez Lazaro Antonia M.,Todoli José A.,Gonzalez Alejos Alba M.,Rodríguez Alvarez Fernando M.,Díaz César,Cubero Marcos José M.,Castillo Laguarta Jesús M.,Polo Angel Dominguez,Lavilla Laura,Ginés Cilia Peralta,Cabello Aurora del Estad,Gómez Escobar Antonio J.,Díaz Concepción,Sarabia Federico Navarro,Hernández Tomás Martín,Sorroche María Gessa,Navarro Elena,Rubio Esteban,Blandón Rafael Villanueva,Maiquez María P.

Funder

Ministerio de Sanidad,Servicios Sociales e Igualdad

Fundación Ramón Domínguez

Publisher

Elsevier BV

Subject

Ophthalmology

Reference32 articles.

1. The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota;Bartley;Trans Am Ophthalmol Soc,1994

2. Incidence and clinical presentation of moderate to severe graves’ orbitopathy in a Danish population before and after iodine fortification of salt;Laurberg;J Clin Endocrinol Metab,2012

3. Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed graves’ hyperthyroidism seen at a single center;Tanda;J Clin Endocrinol Metab,2013

4. Graves’ orbitopathy;Bahn;N Engl J Med,2010

5. Treatment modalities for Graves’ orbitopathy:systematic review and metaanalysis;Stiebel-Kalish;J Clin Endocrinol Metab,2009

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of corticoresistance in patients with Thyroid Eye Disease and use of Rituximab as a second-line treatment;2024-08-16

2. Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review With Meta-analysis;The Journal of Clinical Endocrinology & Metabolism;2024-07-30

3. Graves disease: latest understanding of pathogenesis and treatment options;Nature Reviews Endocrinology;2024-07-22

4. Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy;Advanced Therapeutics;2024-07-05

5. Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials;Thyroid®;2024-07-01